First New York Securities’s Gilead Sciences GILD Stock Holding History

First New York Securities’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-10	Closed	-$700	–	125
2016 Q3	$700	Buy	+10	New	+$812	﹤0.01%	241
2016 Q2	–	Sell	-320	Closed	-$68.5K	–	252
2016 Q1	$68.5K	Buy	+320	New	+$28.9K	0.05%	100

Other funds holding GILD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

First New York Securities's GILD Position: Q2 2014 in Review

First New York Securities sold out of Gilead Sciences (GILD) in Q2 2014, closing a stake of 24,500 shares — an estimated $1.74M sold.

First New York Securities first reported a position in GILD in Q1 2014 and held it in 1 quarter. The position peaked at $1.74M in Q1 2014. 1,262 funds tracked by Wall St. Rank hold GILD as of Q2 2014.

First New York Securities reported no remaining Gilead Sciences position as of Q2 2014 after selling out during the quarter.
First New York Securities sold 24,500 Gilead Sciences shares in Q2 2014, an estimated $1.74M.
First New York Securities first reported a position in Gilead Sciences in Q1 2014 and held it in 1 quarter.
First New York Securities's Gilead Sciences position peaked at $1.74M in Q1 2014.
1,262 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2014.

Based on First New York Securities's 13F filing for Q2 2014, filed 15 Aug 2014.